767: Improvements in the management of placenta accreta Spectrum (PAS): Experience from a single institution
American Journal of Obstetrics and Gynecology. 222(1):S485-S486 [DOI] 10.1016/j.ajog.2019.11.781.
Challenges in Designing a Retrospective Cohort Study to Assess the Clinical Impact of a Diagnostic Test in a Setting Where Alternative Diagnostic Modalities Exist
. [DOI] 10.4135/9781529742725.
Is thromboelastography reliable in postpartum coagulopathies? Two case reports and a literature review
Case Reports in Perinatal Medicine. 9(1) [DOI] 10.1515/crpm-2019-0058.
VP46.04: The value of sonographic (US) and magnetic resonance imaging in the management of placenta accreta spectrum disorders
Ultrasound in Obstetrics & Gynecology. 56(S1):268-269 [DOI] 10.1002/uog.23069.
VP46.22: The value of sonographic markers in the management of placenta accreta spectrum disorders
Ultrasound in Obstetrics & Gynecology. 56(S1):273-273 [DOI] 10.1002/uog.23087.
Is it possible to predict the lower uterine segment thickness by sonographic examination in cases with previous abdominal delivery?
Turkiye Klinikleri Jinekoloji Obstetrik. 20(3):161-164
Prognostic Factors in Epithelial Ovarian Cancer
Turkish Journal of Obstetrics and Gynecology. 7(4):299-304
Deliveries of Macrosomic Babies; Analysis of 746 Cases
Turkiye Klinikleri Journal of Gynecology and Obstetrics. 19(4):211-214
Elevated Plasma Levels of the Tissue Factor Pathway Inhibitor (TFPI) in Gynecologic Cancers
Turkiye Klinikleri Journal of Gynecology and Obstetrics. 18(3):157-160
Residency/Obstetrics and Gynecology2009 · Haseki Training and Research Hospital
M.D.2002 · Istanbul University Cerrahpasa Faculty of Medicine